HPRA Drug Safety Newsletter Edition 114

Download: hpra-drug-safety-newsletter-edition-114.pdf 213 KB

The latest edition of the HPRA newsletter includes important updates to support the safe and appropriate use of the following medicines:

  • Montelukast: New boxed warning to raise further awareness of the risk of neuropsychiatric events
  • Paracetamol: Monitoring risk factors for hepatotoxicity in patients during treatment
  • Ustekinumab: New warning regarding lupus-related conditions and updated advice regarding infections
  • Venlafaxine: Updated warning and advice on complex cases involving overdose and severe poisoning

« Back